- Home
- BME vs EBS Comparison
BME vs EBS Comparison
Compare BME & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BME
- EBS
- Stock Information
- Founded
- BME 2005
- EBS 1998
- Country
- BME United States
- EBS United States
- Employees
- BME N/A
- EBS N/A
- Industry
- BME Trusts Except Educational Religious and Charitable
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- BME Finance
- EBS Health Care
- Exchange
- BME Nasdaq
- EBS Nasdaq
- Market Cap
- BME 462.3M
- EBS 393.9M
- IPO Year
- BME N/A
- EBS 2006
- Fundamental
- Price
- BME $36.27
- EBS $6.64
- Analyst Decision
- BME
- EBS Strong Buy
- Analyst Count
- BME 0
- EBS 3
- Target Price
- BME N/A
- EBS $14.33
- AVG Volume (30 Days)
- BME 34.0K
- EBS 1.2M
- Earning Date
- BME 01-01-0001
- EBS 05-07-2025
- Dividend Yield
- BME 6.26%
- EBS N/A
- EPS Growth
- BME N/A
- EBS N/A
- EPS
- BME 1.44
- EBS N/A
- Revenue
- BME N/A
- EBS $965,400,000.00
- Revenue This Year
- BME N/A
- EBS N/A
- Revenue Next Year
- BME N/A
- EBS $18.88
- P/E Ratio
- BME $28.37
- EBS N/A
- Revenue Growth
- BME N/A
- EBS N/A
- 52 Week Low
- BME $35.53
- EBS $4.02
- 52 Week High
- BME $43.20
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- BME 51.18
- EBS 58.90
- Support Level
- BME $36.00
- EBS $6.01
- Resistance Level
- BME $36.39
- EBS $6.62
- Average True Range (ATR)
- BME 0.40
- EBS 0.37
- MACD
- BME 0.10
- EBS -0.03
- Stochastic Oscillator
- BME 88.35
- EBS 61.88
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.